Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 11/2006

01.11.2006 | Clinical Investigation

Effect of grid laser photocoagulation in diffuse diabetic macular edema in correlation to glycosylated haemoglobin (HbA1c)

verfasst von: Katharina E. Schmid, Beatrix Neumaier-Ammerer, Ulrike Stolba, Susanne Binder

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 11/2006

Einloggen, um Zugang zu erhalten

Abstract

Background

Glycosylated haemoglobin (HbA1c) correlates with the amount of hyperglycemia in diabetic patients. High HbA1c levels often predict clinically significant macular edema (CSME), which then needs to be treated with grid laser photocoagulation. The question asked in this study was whether there is a correlation between the effect grid laser photocoagulation in diffuse diabetic macular edema and HbA1c, using an optical coherence tomography (OCT) for the evaluation of the retinal thickness.

Methods

A prospective, non-comparative case series was performed to find a correlation between the effect of grid laser photocoagulation in diffuse diabetic macular edema and HbA1c. Thirty eyes with CSME of diabetic patients were included in the study. Complete ophthalmic examinations and OCT were performed at baseline, 1 month, 3, and 6 months after grid laser photocoagulation therapy. HbA1c was measured at the end of study.

Results

Significance level was set at P<0.05. A significant difference in the foveal (P=0.02) and superior (P=0.021) retinal thickness 6 months after laser therapy, no correlation between HbA1c and retinal thickness after photocoagulation, and an insignificant decrease in visual acuity (P=0.9) were found. The correlation between foveal retinal thickness and visual acuity was P=0.24 6 months after treatment.

Conclusion

There was no significant correlation between HbA1c and the effect of grid laser photocoagulation therapy in diffuse diabetic macular edema. The retinal thickness decreased significantly in the foveal and superior area 6 months after therapy. No correlation between the foveal retinal thickness and the visual acuity was found. The visual acuity did not increase after treatment. There are many factors influencing the retinal thickness, such as the blood pressure and the attached posterior hyaloid.
Literatur
1.
Zurück zum Zitat Baumann M, Gentile RC, Liebmann JM, Ritch R (1998) Reproducibility of retinal thickness measurements in normal eyes using optical coherence tomography. Ophthalmic Surg Lasers 29:280–285 Baumann M, Gentile RC, Liebmann JM, Ritch R (1998) Reproducibility of retinal thickness measurements in normal eyes using optical coherence tomography. Ophthalmic Surg Lasers 29:280–285
2.
Zurück zum Zitat Besenthal I (2000) Glukosestoffwechsel. In: Neumeister B, Besenthal I, Liebich H (eds) Klinikleitfaden Labordiagnostik. Urban und Fischer Verlag, München Jena, pp 126–127 Besenthal I (2000) Glukosestoffwechsel. In: Neumeister B, Besenthal I, Liebich H (eds) Klinikleitfaden Labordiagnostik. Urban und Fischer Verlag, München Jena, pp 126–127
3.
4.
Zurück zum Zitat Bresnick GH (1983) Diabetic maculopathy. A critical review highlighting diffuse macular edema. Ophthalmology 90:1301–1317PubMed Bresnick GH (1983) Diabetic maculopathy. A critical review highlighting diffuse macular edema. Ophthalmology 90:1301–1317PubMed
5.
Zurück zum Zitat Capone A Jr, Panozzo G (2000) Vitrectomy for refractory diabetic macular edema. Semin Ophthalmol 15:78–80PubMedCrossRef Capone A Jr, Panozzo G (2000) Vitrectomy for refractory diabetic macular edema. Semin Ophthalmol 15:78–80PubMedCrossRef
6.
Zurück zum Zitat Chantelau E (2001) What may be gained from standard photocoagulation during early worsening of diabetic retinopathy? An observational study in type-1 diabetic patients after tightening of glycemic control. Diabetes Metab 27:366–371PubMed Chantelau E (2001) What may be gained from standard photocoagulation during early worsening of diabetic retinopathy? An observational study in type-1 diabetic patients after tightening of glycemic control. Diabetes Metab 27:366–371PubMed
7.
Zurück zum Zitat Chauhan DS, Marshall J (1999) The interpretation of optical coherence tomography images of the retina. Invest Ophthalmol Vis Sci 40:2332–2342PubMed Chauhan DS, Marshall J (1999) The interpretation of optical coherence tomography images of the retina. Invest Ophthalmol Vis Sci 40:2332–2342PubMed
8.
Zurück zum Zitat Early Treatment Diabetic Retinopathy Study Research Group (1991) ETDRS report number 7: Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. Ophthalmology 98:741–756 Early Treatment Diabetic Retinopathy Study Research Group (1991) ETDRS report number 7: Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. Ophthalmology 98:741–756
9.
Zurück zum Zitat Frank RN, Schulz L, Abe K, Iezzi R (2004) Temporal variation in diabetic macular edema measured by optical coherence tomography. Ophthalmology 111:211–217CrossRefPubMed Frank RN, Schulz L, Abe K, Iezzi R (2004) Temporal variation in diabetic macular edema measured by optical coherence tomography. Ophthalmology 111:211–217CrossRefPubMed
10.
Zurück zum Zitat Goebel W, Kretzchmar-Gross T (2002) Retinal thickness in diabetic retinopathy: a study using optical coherence tomography (OCT). Retina 22:759–767CrossRefPubMed Goebel W, Kretzchmar-Gross T (2002) Retinal thickness in diabetic retinopathy: a study using optical coherence tomography (OCT). Retina 22:759–767CrossRefPubMed
11.
Zurück zum Zitat Hee MR, Izatt JA, Swanson EA, Huang D, Schuman JS, Lin CP, Puliafito CA, Fujimoto JG (1995) Optical coherence tomography of the human retina. Arch Ophthalmol 113:325–332PubMed Hee MR, Izatt JA, Swanson EA, Huang D, Schuman JS, Lin CP, Puliafito CA, Fujimoto JG (1995) Optical coherence tomography of the human retina. Arch Ophthalmol 113:325–332PubMed
12.
Zurück zum Zitat Hee MR, Puliafito CA, Duker JS, Reichel E, Coker JG, Wilkins JR, Schuman JS, Swanson EA, Fujimoto JG (1998) Topography of diabetic macular edema with optical coherence tomography. Ophthalmology 105:360–370CrossRefPubMed Hee MR, Puliafito CA, Duker JS, Reichel E, Coker JG, Wilkins JR, Schuman JS, Swanson EA, Fujimoto JG (1998) Topography of diabetic macular edema with optical coherence tomography. Ophthalmology 105:360–370CrossRefPubMed
13.
Zurück zum Zitat Hee MR, Puliafito CA, Wong C, Duker JS, Reichel E, Rutledge B, Schuman JS, Swanson EA, Fujimoto JG (1995) Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol 113:1019–1029PubMed Hee MR, Puliafito CA, Wong C, Duker JS, Reichel E, Rutledge B, Schuman JS, Swanson EA, Fujimoto JG (1995) Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol 113:1019–1029PubMed
14.
Zurück zum Zitat Hikichi T, Fujio N, Akiba Y, Takahashi M, Yoshida A (1997) Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus. Ophthalmology 104:473–478PubMed Hikichi T, Fujio N, Akiba Y, Takahashi M, Yoshida A (1997) Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus. Ophthalmology 104:473–478PubMed
15.
Zurück zum Zitat Izatt JA, Hee MR, Swanson EA, Lin CP, Huang D, Schuman JS, Puliafito CA, Fujimoto JG (1994) Micrometer-scale resolution imaging of the anterior eye in vivo with optical coherence tomography. Arch Ophthalmol 112:1548–1589 Izatt JA, Hee MR, Swanson EA, Lin CP, Huang D, Schuman JS, Puliafito CA, Fujimoto JG (1994) Micrometer-scale resolution imaging of the anterior eye in vivo with optical coherence tomography. Arch Ophthalmol 112:1548–1589
16.
Zurück zum Zitat Kang SW, Park CY, Ham DI (2004) The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema. Am J Ophthalmol 137:313–322CrossRefPubMed Kang SW, Park CY, Ham DI (2004) The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema. Am J Ophthalmol 137:313–322CrossRefPubMed
17.
Zurück zum Zitat Klein R, Klein BE, Moss SE (1984) Visual impairement in diabetes. Ophthalmology 91:1–19 Klein R, Klein BE, Moss SE (1984) Visual impairement in diabetes. Ophthalmology 91:1–19
18.
Zurück zum Zitat Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin Epidemiologic Study of Diabetic Retinopathy, IV: diabetic macular edema. Ophthalmology 91:1464–1474PubMed Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin Epidemiologic Study of Diabetic Retinopathy, IV: diabetic macular edema. Ophthalmology 91:1464–1474PubMed
19.
Zurück zum Zitat Klein R, Moss SE, Klein BE, Davis MD, DeMets DL (1989) The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology 96:1501–1510PubMed Klein R, Moss SE, Klein BE, Davis MD, DeMets DL (1989) The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology 96:1501–1510PubMed
20.
Zurück zum Zitat Kojima T, Terasaki H, Nomura H, Suzuki T, Mori M, Ito Y, Miyake Y (2003) Vitrectomy for diabetic macular edema: effect of glycemic control (HbA(1c)), renal function (creatinine) and other local factors. Ophthalmic Res 35:192–198CrossRefPubMed Kojima T, Terasaki H, Nomura H, Suzuki T, Mori M, Ito Y, Miyake Y (2003) Vitrectomy for diabetic macular edema: effect of glycemic control (HbA(1c)), renal function (creatinine) and other local factors. Ophthalmic Res 35:192–198CrossRefPubMed
21.
Zurück zum Zitat Kremser BG, Kunze C, Troger J, Ulmer H, Kieselbach GK (1996) Grid pattern photocoagulation for diabetic macular edema–long term visual results. Ophthalmologica 210:160–162PubMed Kremser BG, Kunze C, Troger J, Ulmer H, Kieselbach GK (1996) Grid pattern photocoagulation for diabetic macular edema–long term visual results. Ophthalmologica 210:160–162PubMed
22.
Zurück zum Zitat Lattanzio R, Brancato R, Pierro L, Bandello F, Iaccher B, Fiore T, Maestranzi G (2002) Macular thickness measured by optical coherence tomography (OCT) in diabetic patients. Eur J Ophthalmol 12:482–487PubMed Lattanzio R, Brancato R, Pierro L, Bandello F, Iaccher B, Fiore T, Maestranzi G (2002) Macular thickness measured by optical coherence tomography (OCT) in diabetic patients. Eur J Ophthalmol 12:482–487PubMed
23.
Zurück zum Zitat Lee CM, Olk RJ (1991) Modified grid laser photocoagulation for diffuse diabetic macular edema: long-term visual results. Ophthalmology 98:1594–1602PubMed Lee CM, Olk RJ (1991) Modified grid laser photocoagulation for diffuse diabetic macular edema: long-term visual results. Ophthalmology 98:1594–1602PubMed
24.
Zurück zum Zitat Lopes de Faria JM, Jalkh AE, Trempe CL, McMeel JW (1999) Diabetic macular edema: risk factors and concomitants. Acta Ophthalmol Scand 77:170–175CrossRefPubMed Lopes de Faria JM, Jalkh AE, Trempe CL, McMeel JW (1999) Diabetic macular edema: risk factors and concomitants. Acta Ophthalmol Scand 77:170–175CrossRefPubMed
25.
Zurück zum Zitat Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C (2002) Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109:920–927CrossRefPubMed Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C (2002) Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109:920–927CrossRefPubMed
26.
Zurück zum Zitat Massin P, Viscaut E, Haouchine B, Erginay A, Paques M, Gaudric A (2001) Reproducibility of retinal mapping using optical coherence tomography. Arch Ophthalmol 119:1135–1142PubMed Massin P, Viscaut E, Haouchine B, Erginay A, Paques M, Gaudric A (2001) Reproducibility of retinal mapping using optical coherence tomography. Arch Ophthalmol 119:1135–1142PubMed
27.
Zurück zum Zitat McDonald HR, Schatz H (1985) Macular edema following panretinal photocoagulation. Retina 5:5–10PubMedCrossRef McDonald HR, Schatz H (1985) Macular edema following panretinal photocoagulation. Retina 5:5–10PubMedCrossRef
28.
Zurück zum Zitat Moreira RO, Trujillo FR, Meirelles RM, Ellinger VC, Zagury L (2001) Use of optical coherence tomography (OCT) and indirect ophthalmoscopy in the diagnosis of macular edema in diabetic patients. Int Ophthalmol 24:331–336CrossRefPubMed Moreira RO, Trujillo FR, Meirelles RM, Ellinger VC, Zagury L (2001) Use of optical coherence tomography (OCT) and indirect ophthalmoscopy in the diagnosis of macular edema in diabetic patients. Int Ophthalmol 24:331–336CrossRefPubMed
29.
Zurück zum Zitat Nasrallah FP, Jalkh AE, Van Coppenrolle F, Kado M, Trempe CL, McMeel JW, Schepens CL (1988) The role of the vitreous in diabetic macular edema. Ophthalmology 95:1335–1339PubMed Nasrallah FP, Jalkh AE, Van Coppenrolle F, Kado M, Trempe CL, McMeel JW, Schepens CL (1988) The role of the vitreous in diabetic macular edema. Ophthalmology 95:1335–1339PubMed
30.
Zurück zum Zitat Nasrallah FP, Van de Velde F, Jalkh AE, Trempe CL, McMeel JW, Schepens CL (1989) Importance of the vitreous in young diabetics with macular edema. Ophthalmology 96:1511–1517PubMed Nasrallah FP, Van de Velde F, Jalkh AE, Trempe CL, McMeel JW, Schepens CL (1989) Importance of the vitreous in young diabetics with macular edema. Ophthalmology 96:1511–1517PubMed
31.
Zurück zum Zitat Olk RJ (1986) Modified grid blue-green laser photocoagulation for diffuse diabetic macular edema. Ophthalmology 93:938–950PubMed Olk RJ (1986) Modified grid blue-green laser photocoagulation for diffuse diabetic macular edema. Ophthalmology 93:938–950PubMed
32.
Zurück zum Zitat Olk RJ (1990) Argon green (514 nm) versus krypton red (647 nm) modified grid laser photocoagulation for diffuse diabetic macular edema. Ophthalmology 97:1101–1112PubMed Olk RJ (1990) Argon green (514 nm) versus krypton red (647 nm) modified grid laser photocoagulation for diffuse diabetic macular edema. Ophthalmology 97:1101–1112PubMed
33.
Zurück zum Zitat Otani T, Kishi S, Maruyama Y (1999) Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol 127:688–693CrossRefPubMed Otani T, Kishi S, Maruyama Y (1999) Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol 127:688–693CrossRefPubMed
34.
Zurück zum Zitat Perkovich BT, Meyers SM (1988) Systemic factors affecting diabetic macular edema. Am J Ophthalmol 105:211–212PubMed Perkovich BT, Meyers SM (1988) Systemic factors affecting diabetic macular edema. Am J Ophthalmol 105:211–212PubMed
35.
Zurück zum Zitat Pieroth L, Schuman JS, Hertzmark E, Hee MR, Wilkins JR, Coker J, Mattox C, Pedut-Kloizman R, Puliafito CA, Fujimoto JG, Swanson E (1999) Evaluation of focal defects of the nerve fiber layer using optical coherence tomography. Ophthalmology 106:570–579CrossRefPubMed Pieroth L, Schuman JS, Hertzmark E, Hee MR, Wilkins JR, Coker J, Mattox C, Pedut-Kloizman R, Puliafito CA, Fujimoto JG, Swanson E (1999) Evaluation of focal defects of the nerve fiber layer using optical coherence tomography. Ophthalmology 106:570–579CrossRefPubMed
36.
Zurück zum Zitat Puliafito CA, Hee MR, Lin CP, Reichel E, Schuman JS, Duker JS, Izatt JA, Swanson EA, Fujimoto JG (1995) Imaging of macular disease with optical coherence tomography. Ophthalmology 102:217–229PubMed Puliafito CA, Hee MR, Lin CP, Reichel E, Schuman JS, Duker JS, Izatt JA, Swanson EA, Fujimoto JG (1995) Imaging of macular disease with optical coherence tomography. Ophthalmology 102:217–229PubMed
37.
Zurück zum Zitat Sanchez-Tocino H, Alvarez-Vidal A, Maldonado MJ, Moreno-Montanes J, Garcia-Layana A (2002) Retinal thickness study with optical coherence tomography in patients with diabetes. Invest Ophthalmol Vis Sci 43:1588–1594PubMed Sanchez-Tocino H, Alvarez-Vidal A, Maldonado MJ, Moreno-Montanes J, Garcia-Layana A (2002) Retinal thickness study with optical coherence tomography in patients with diabetes. Invest Ophthalmol Vis Sci 43:1588–1594PubMed
38.
Zurück zum Zitat Schaudig UH, Glaefke C, Scholz F, Richard G (2000) Optical coherence tomography for retinal thickness measurement in diabetic patients without clinically significant macular edema. Ophthalmic Surg Lasers 31:182–186PubMed Schaudig UH, Glaefke C, Scholz F, Richard G (2000) Optical coherence tomography for retinal thickness measurement in diabetic patients without clinically significant macular edema. Ophthalmic Surg Lasers 31:182–186PubMed
39.
Zurück zum Zitat Sebag J, Balazs EA (1984) Pathogenesis of CME: anatomic consideration of vitreoretinal adhesions. Surv Ophthalmol 29(suppl):493–498CrossRef Sebag J, Balazs EA (1984) Pathogenesis of CME: anatomic consideration of vitreoretinal adhesions. Surv Ophthalmol 29(suppl):493–498CrossRef
40.
Zurück zum Zitat Sebag J, Buckingham B, Charles MA, Reiser K (1992) Biochemical abnormalities of vitreous in humans with proliferative diabetic retinopathy. Arch Ophthalmol 110:1472–1476PubMed Sebag J, Buckingham B, Charles MA, Reiser K (1992) Biochemical abnormalities of vitreous in humans with proliferative diabetic retinopathy. Arch Ophthalmol 110:1472–1476PubMed
41.
Zurück zum Zitat Sebag J, Nie S, Reiser K, Charles MA, Yu NT (1994) Raman spectroscopy of human vitreous in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 35:2976–2980PubMed Sebag J, Nie S, Reiser K, Charles MA, Yu NT (1994) Raman spectroscopy of human vitreous in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 35:2976–2980PubMed
42.
Zurück zum Zitat Stefaniotou M, Kalogeropoulos C, Psilas K (1995) Long-term visual results after laser photocoagulation for diabetic maculopathy. Ophthalmologica 209:64–67PubMedCrossRef Stefaniotou M, Kalogeropoulos C, Psilas K (1995) Long-term visual results after laser photocoagulation for diabetic maculopathy. Ophthalmologica 209:64–67PubMedCrossRef
43.
Zurück zum Zitat Stolba U, Binder S, Gruber D, Krebs I, Aggermann T, Neumaier-Ammerer B (2005) Vitrectomy for persistent diffuse diabetic macular edema. Am J Ophthalmol 140:295–301CrossRefPubMed Stolba U, Binder S, Gruber D, Krebs I, Aggermann T, Neumaier-Ammerer B (2005) Vitrectomy for persistent diffuse diabetic macular edema. Am J Ophthalmol 140:295–301CrossRefPubMed
44.
Zurück zum Zitat Toth CA, Narayan DG, Boppart SA, Hee MR, Fujimoto JG, Birngruber R, Cain CP, DiCarlo CD, Roach WP (1997) A comparison of retinal morphology viewed by optical coherence tomography and by light microscopy. Arch Ophthalmol 115:1425–1428PubMed Toth CA, Narayan DG, Boppart SA, Hee MR, Fujimoto JG, Birngruber R, Cain CP, DiCarlo CD, Roach WP (1997) A comparison of retinal morphology viewed by optical coherence tomography and by light microscopy. Arch Ophthalmol 115:1425–1428PubMed
45.
Zurück zum Zitat Varano M, Scassa C, Ripandelli G, Capaldo N (1999) New diagnostic tools for macular edema. Doc Ophthalmol 97:373–379CrossRefPubMed Varano M, Scassa C, Ripandelli G, Capaldo N (1999) New diagnostic tools for macular edema. Doc Ophthalmol 97:373–379CrossRefPubMed
46.
Zurück zum Zitat Yamamoto S, Yamamoto T, Hayahi M, Takeuchi S (2001) Morphological and functional analyses of diabetic macular edema by optical coherence tomography and multifocal electroretinograms. Graefe's Arch Ophthalmol 239:96–101 Yamamoto S, Yamamoto T, Hayahi M, Takeuchi S (2001) Morphological and functional analyses of diabetic macular edema by optical coherence tomography and multifocal electroretinograms. Graefe's Arch Ophthalmol 239:96–101
47.
Zurück zum Zitat Yang CS, Cheng CY, Lee CF, Hsu WM, Liu JH (2001) Quantitative assessment of retinal thickness in diabetic patients with and without clinically significant macular edema using optical coherence tomography. Acta Ophthalmol Scand 79:266–270CrossRefPubMed Yang CS, Cheng CY, Lee CF, Hsu WM, Liu JH (2001) Quantitative assessment of retinal thickness in diabetic patients with and without clinically significant macular edema using optical coherence tomography. Acta Ophthalmol Scand 79:266–270CrossRefPubMed
48.
Zurück zum Zitat Yanoff M, Fine BS (1996) Diabetes mellitus. In: Yanoff M, Fine BS (eds) Ocular pathology. Mosby-Wolfe, London, pp 563–565 Yanoff M, Fine BS (1996) Diabetes mellitus. In: Yanoff M, Fine BS (eds) Ocular pathology. Mosby-Wolfe, London, pp 563–565
Metadaten
Titel
Effect of grid laser photocoagulation in diffuse diabetic macular edema in correlation to glycosylated haemoglobin (HbA1c)
verfasst von
Katharina E. Schmid
Beatrix Neumaier-Ammerer
Ulrike Stolba
Susanne Binder
Publikationsdatum
01.11.2006
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 11/2006
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-006-0322-6

Weitere Artikel der Ausgabe 11/2006

Graefe's Archive for Clinical and Experimental Ophthalmology 11/2006 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.